Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
Deepak Singhal, Christopher N Hahn, Simone Feurstein, Li Yan A. Wee, Luke Moma, Monika Kutyna, Rakchha Chhetri, Leila Eshraghi, Andreas Schreiber, Jinghua Feng, Paul Wang, Milena Babic, Wendy T Parker, Song Gao, Sarah Moore, Soma Das, David M. Thomas, Swetansu Pattnaik, Anna Brown, Richard J. D’Andrea, Nicola Poplawski, Danièl Thomas, Hamish S. Scott, Lucy A. Godley, Devendra Hiwase
Topics & Concepts
CHEK2GermlineMalignancyCancerInternal medicineOncologyMedicineMyeloidLi–Fraumeni syndromeGermline mutationBiologyGeneticsGeneMutationAcute Myeloid Leukemia ResearchCancer Genomics and DiagnosticsGenetic factors in colorectal cancer